OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
47
Results
Show all
Save search
Copy query
Show results for
Unknown
(47)
Publication Date
Release Date
2018
(29)
2022
(5)
2023
(4)
2021
(4)
2025
(2)
2020
(2)
2024
(1)
Previous
page
1 / 5
You're on page
1
page
2
page
3
page
4
page
5
Next
page
Sort
by:
Relevance
Page size
10
Protocol for a comprehensive prospective cohort study of trio-based whole-genome sequencing for underlying cancer predisposition in paediatric and adolescent patients newly diagnosed with cancer: the PREDICT study.
Not available
S-EPMC10254808
|
biostudies-literature
Cite
A novel transcriptional signature identifies T-cell infiltration in high-risk paediatric cancer.
Not available
S-EPMC10071693
|
biostudies-literature
Cite
Precision-guided treatment in high-risk pediatric cancers.
Not available
S-EPMC11271405
|
biostudies-literature
Cite
Managing food allergy: GA
2
LEN guideline 2022.
Not available
S-EPMC9467869
|
biostudies-literature
Cite
A Pan-Cancer Analysis of Enhancer Expression in Nearly 9000 Patient Samples.
Not available
S-EPMC5890960
|
biostudies-literature
Cite
A Comprehensive Pan-Cancer Molecular Study of Gynecologic and Breast Cancers.
Not available
S-EPMC5959730
|
biostudies-literature
Cite
Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Not available
S-EPMC7884931
|
biostudies-literature
Cite
Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Not available
S-EPMC8598213
|
biostudies-literature
Cite
Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Not available
S-EPMC10957483
|
biostudies-literature
Cite
Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Not available
S-EPMC8084355
|
biostudies-literature
Cite
Previous
page
1 / 5
You're on page
1
page
2
page
3
page
4
page
5
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets